1.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTXR Giù?
Forum
Previsione
Frazionamento azionario
Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie
Citius Oncology prepares for lymphoma treatment launch in 2025 By Investing.com - Investing.com Nigeria
Citius Oncology On Track to Launch Lymphir in US in H2 - MarketScreener
Citius Oncology prepares for lymphoma treatment launch in 2025 - Investing.com
Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PR Newswire
Millennium Management LLC Sells 1,126,188 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World
Citius Oncology enters distribution services agreement with Cardinal Health - MSN
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - The Victoria Advocate
Citius Pharmaceuticals Closes $6M Securities Offering - TipRanks
After Major Oncology Conference, All Eyes Turn to Industry Innovation - Quantisnow
Citius Pharmaceuticals Announces Closing Of Registered Direct Offering Of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - MarketScreener
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules | CTXR Stock News - GuruFocus
Citius Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow
Citius Pharmaceuticals Secures $15.8M Financing Deal: What This Means for LYMPHIR Commercialization - Stock Titan
Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Longview News-Journal
Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundrais - GuruFocus
Citius Pharma secures $6 million in stock offering By Investing.com - Investing.com South Africa
Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundraising Efforts | CTXR Stock News - GuruFocus
Citius Pharmaceuticals Stock Is Falling Tuesday: What's Going On? - Benzinga
Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offeri - GuruFocus
Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offering - GuruFocus
Citius Pharmaceuticals (CTXR) Price Target Lowered, Rating Maint - GuruFocus
Citius Pharmaceuticals announces registered direct offering of $15.8 million - MSN
Citius Pharma secures $6 million in stock offering - Investing.com Australia
Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offeri - GuruFocus
Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offering | CTXR Stock News - GuruFocus
Citius Pharma Announces Direct Offering - Nasdaq
Citius Pharmaceuticals Announces a Registered Direct Offering of - GuruFocus
Citius Pharmaceuticals (NASDAQ:CTXR) Given “Buy” Rating at D. Boral Capital - Defense World
Citius Pharmaceuticals expands authorized shares By Investing.com - Investing.com Nigeria
Citius Oncology partners with Cardinal Health for LYMPHIR distribution By Investing.com - Investing.com South Africa
Citius Pharmaceuticals (CTXR) Receives Continued Buy Rating from Analyst | CTXR Stock News - GuruFocus
Citius Pharmaceuticals expands authorized shares - Investing.com
Citius Pharmaceuticals Stock Is Soaring Monday: What's Going On? - Benzinga
Citius Oncology Signs US Distribution Deal With Cardinal Health for Lymphir - marketscreener.com
Cardinal Health (CAH) Partners with Citius Oncology for LYMPHIR Distribution | CAH Stock News - GuruFocus
Citius Oncology Inks Distribution Services Agreement With Cardinal Health For LYMPHIR - Nasdaq
Citius Oncology stock soars on distribution deal By Investing.com - Investing.com South Africa
Citius Oncology stock soars on distribution deal - Investing.com Australia
Citius Oncology partners with Cardinal Health for LYMPHIR distribution - Investing.com
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health | CTXR Stock News - GuruFocus
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health - Yahoo Finance
Squarepoint Ops LLC Sells 609,711 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World
Northern Trust Corp Sells 306,583 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - mx.advfn.com
Citius Pharmaceuticals Issues $1M Promissory Note to Pagoda - TipRanks
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Receives $54.50 Consensus Price Target from Brokerages - Defense World
Why Shares of SoundHound AI Are Soaring Today - The Globe and Mail
Citius Pharmaceuticals (NASDAQ:CTXR) Cut to Hold at Maxim Group - Defense World
Maxim Group Downgrades Citius Pharmaceuticals (CTXR) - MSN
This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim Group - GuruFocus
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):